Insights

Loading spinner
Gathering insights about Imvaq Therapeutics

Imvaq Therapeutics Tech Stack

Imvaq Therapeutics uses 5 technology products and services including Gentoo, Lua, PHP, and more. Explore Imvaq Therapeutics's tech stack below.

  • Gentoo
    Operating Systems
  • Lua
    Programming Languages
  • PHP
    Programming Languages
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Media & News

Imvaq Therapeutics's Email Address Formats

Imvaq Therapeutics uses at least 1 format(s):
Imvaq Therapeutics Email FormatsExamplePercentage
FLast@imvaq.comJDoe@imvaq.com
38%
First@imvaq.comJohn@imvaq.com
12%
FLast@imvaq.comJDoe@imvaq.com
38%
First@imvaq.comJohn@imvaq.com
12%

Frequently Asked Questions

Where is Imvaq Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Imvaq Therapeutics's main headquarters is located at York Avenue New York, New York United States. The company has employees across 1 continents, including North America.

What is Imvaq Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Imvaq Therapeutics's official website is imvaq.com and has social profiles on LinkedIn.

What is Imvaq Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Imvaq Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Imvaq Therapeutics have currently?

Minus sign iconPlus sign icon
As of February 2026, Imvaq Therapeutics has approximately 3 employees across 1 continents, including North America. Key team members include Vice President, Manufacturing: L. W.. Explore Imvaq Therapeutics's employee directory with LeadIQ.

What industry does Imvaq Therapeutics belong to?

Minus sign iconPlus sign icon
Imvaq Therapeutics operates in the Biotechnology Research industry.

What technology does Imvaq Therapeutics use?

Minus sign iconPlus sign icon
Imvaq Therapeutics's tech stack includes GentooLuaPHPOpenRestyNginx.

What is Imvaq Therapeutics's email format?

Minus sign iconPlus sign icon
Imvaq Therapeutics's email format typically follows the pattern of FLast@imvaq.com. Find more Imvaq Therapeutics email formats with LeadIQ.

How much funding has Imvaq Therapeutics raised to date?

Minus sign iconPlus sign icon
As of February 2026, Imvaq Therapeutics has raised $20M in funding. The last funding round occurred on Aug 31, 2020 for $20M.

Imvaq Therapeutics

Biotechnology ResearchNew York, United States2-10 Employees

Imvaq is an innovative biotechnology company developing novel immuno-oncologics to treat metastatic cancer.

Based on the research of Imvaq's distinguished scientific founders at Memorial Sloan Kettering Cancer Center, one of the leading clinical and R&D cancer hospitals in the world, we are focused on creating therapeutic products that synergize with a patient's own immune system to eradicate the cancer, locally and abscopally.

Section iconCompany Overview

Headquarters
York Avenue New York, New York United States
Website
imvaq.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $20M

    Imvaq Therapeutics has raised a total of $20M of funding over 1 rounds. Their latest funding round was raised on Aug 31, 2020 in the amount of $20M.

  • $1M

    Imvaq Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $20M

    Imvaq Therapeutics has raised a total of $20M of funding over 1 rounds. Their latest funding round was raised on Aug 31, 2020 in the amount of $20M.

  • $1M

    Imvaq Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.